An Experimental Weight-Loss Drug Shows Lasting Results in Early Study
An experimental weight-loss shot from Amgen Inc.—taken less frequently than wildly popular treatments from Eli Lilly & Co. and Novo Nordisk A/S—appears to keep weight off even after patients stop taking it.
Patients given a monthly injection of Amgen’s drug, dubbed MariTide, lost up to 14.5% of their body weight in just 12 weeks, according to a small, early-stage study published Monday in the journal Nature Metabolism. And some people kept the weight off for up to 150 days after stopping the drug, findings show.
[time-brightcove not-tgx=”true”]
“That is really a remarkable and...
Source: TIME: Health - February 5, 2024 Category: Consumer Health News Authors: Madison Muller/Bloomberg Tags: Uncategorized bloomberg wire healthscienceclimate Source Type: news
Wearable Device Tracks IBD From Sweat Wearable Device Tracks IBD From Sweat
A novel wearable device shows initial promise for measuring disease status from perspiration in patients with IBD.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 5, 2024 Category: Consumer Health News Tags: Gastroenterology Source Type: news
Laparoscopic SG, RYGB Carry Similar, Low Perioperative Risk Laparoscopic SG, RYGB Carry Similar, Low Perioperative Risk
The perioperative risk is similar and low for SG and RYGB, so that the risk should not be a deciding factor in the choice of method for bariatric surgery.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - February 5, 2024 Category: Endocrinology Tags: Gastroenterology Source Type: news
Cell-Free DNA May Inform IBD Diagnosis Cell-Free DNA May Inform IBD Diagnosis
In patients with IBD, measurement of microbial cell-free DNA in plasma may help distinguish active from asymptomatic disease, as well as between ulcerative colitis and Crohn ' s disease.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 5, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news
What is the Differential Diagnosis of a Suprarenal Mass?
Discussion
Suprarenal masses (SRM) are not that common (incidence of 1.9/1000 in neonates), but are more commonly diagnosed prenatally because of prenatal ultrasound. Masses can be difficult to accurately diagnose even after birth because their features overlap. Radiographically they can be variable in size, cystic/solid or mixed and with or without calcifications. Common signs and symptoms of SRM include anemia, jaundice, scrotal hematoma and abdominal mass. Signs of asphyxia may also occur. Often patients whose diagnosis is not clear are monitored closely for a few weeks to see how the lesion changes with time. This is e...
Source: PediatricEducation.org - February 5, 2024 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Dose Escalation With Infliximab Biosimilar Can Restore Responses in IBD
(MedPage Today) -- LAS VEGAS -- In patients with inflammatory bowel disease who lost response after infliximab (Remicade) induction, escalating the maintenance dose of the subcutaneous infliximab biosimilar CT-P13 improved clinical response and... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - February 3, 2024 Category: Gastroenterology Source Type: news
Nearly 140 people onboard a cruise ship sick in gastrointestinal illness outbreak
Create your free profile or log in to save this article Create your free profile or log in to save this article Around 140 people have fallen sick with a gastrointestinal illness onboard the Cunard Queen Victoria cruise ship that docked in Fort Lauderdale, Florida, on Jan. 22 when the CDC began…#fortlauderdale #florida #cdc #queenvictoria #honolulu #oceania #cunard #cunardcruiseline (Source: Reuters: Health)
Source: Reuters: Health - February 2, 2024 Category: Consumer Health News Source Type: news
Bariatric Surgeries Carry Low Perioperative Risks
FRIDAY, Feb. 2, 2024 -- Laparoscopic sleeve gastrectomy (SG) and laparoscopic Roux-en-Y gastric bypass (RYGB) have similarly low perioperative risk among adults with obesity, according to a study published online Jan. 30 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 2, 2024 Category: Pharmaceuticals Source Type: news
How to Manage Immune Checkpoint Inhibitor Hepatotoxicity How to Manage Immune Checkpoint Inhibitor Hepatotoxicity
Because liver toxicity can be a sign that these drugs are working, knowing how to manage this adverse event can help patients reap the full benefit, says Dr David Johnson.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 2, 2024 Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news
'I'm a gastroenterologist - here are two symptoms of gallbladder disease'
One of the red flag signs of gallbladder disease can appear after you eat fatty foods, according to a doctor. (Source: Daily Express - Health)
Source: Daily Express - Health - February 2, 2024 Category: Consumer Health News Source Type: news
Severe hepatotoxicity in mushroom poisoning by Lepiota brunneoincarnata from complete recovery to liver transplantation: a case series with review on liver function tests and liver histopathology - Anbardar MH, Soleimani N, Kazemi K, Jafarpour Z, Hasani M, Mohammadzadeh S, Torfehnezhad P, Jafarian S, Farhadi M, Sardari MS.
BACKGROUND: In spite of the scientific evidence supporting health advantages of mushrooms, some of them are seriously poisonous. The clinical picture of mushroom intoxication ranges from minor gastrointestinal symptoms to organ failure, such as liver failu... (Source: SafetyLit)
Source: SafetyLit - February 1, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
GSK Settles Another Zantac Lawsuit in California GSK Settles Another Zantac Lawsuit in California
GSK said on Thursday it had agreed to settle another lawsuit in California that alleged its discontinued heartburn drug Zantac caused cancer, the latest in a series of...Reuters Health Information (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - February 1, 2024 Category: Primary Care Tags: Gastroenterology Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline
Group salesgrow by 1%1 at constant exchange rates (CER; -7% in CHF), more than offsetting the decline in COVID-19-related sales and biosimilar erosion, and thereby exceeding 2023 guidanceExcluding COVID-19 products,Group sales increase by 8%Pharmaceuticals Divisionsalesincrease by 6% (excluding COVID-19 medicine Ronapreve: +9%) due to ongoing high demand for newer medicines, with eye medicine Vabysmo continuing to be the top growth driver, followed by Ocrevus (multiple sclerosis), Hemlibra (haemophilia A) and Polivy (blood cancer)Diagnostics Division salesare 13% lower due to high demand for COVID-19 tests in 2022; strong ...
Source: Roche Media News - February 1, 2024 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline
Group salesgrow by 1%1 at constant exchange rates (CER; -7% in CHF), more than offsetting the decline in COVID-19-related sales and biosimilar erosion, and thereby exceeding 2023 guidanceExcluding COVID-19 products,Group sales increase by 8%Pharmaceuticals Divisionsalesincrease by 6% (excluding COVID-19 medicine Ronapreve: +9%) due to ongoing high demand for newer medicines, with eye medicine Vabysmo continuing to be the top growth driver, followed by Ocrevus (multiple sclerosis), Hemlibra (haemophilia A) and Polivy (blood cancer)Diagnostics Division salesare 13% lower due to high demand for COVID-19 tests in 2022; strong ...
Source: Roche Investor Update - February 1, 2024 Category: Pharmaceuticals Source Type: news
IBD Surgery Linked to Improved Patient-Reported Pain, Physical Health
(MedPage Today) -- LAS VEGAS -- Patients who underwent surgery for inflammatory bowel disease (IBD) reported feeling physically better, but not emotionally or socially better, 1 month after surgery, according to a prospective longitudinal cohort... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 31, 2024 Category: Gastroenterology Source Type: news
